Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis

Author:

Bettiol Alessandra1,Emmi Giacomo2,Finocchi Martina2,Silvestri Elena2,Urban Maria Letizia2,Mattioli Irene2,Scalera Antonella3,Lupoli Roberta4,Vannacci Alfredo1,Di Minno Matteo Nicola Dario4ORCID,Prisco Domenico1

Affiliation:

1. Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA)

2. Department of Experimental and Clinical Medicine, University of Firenze, Firenze

3. Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy

4. Department of Translational Medical Sciences, Federico II University, Naples, Italy

Abstract

Abstract Objectives The persistent positivity of aPLs, either isolated or associated with thrombotic and/or obstetric events (APS), has been associated with the increase of intima-media thickness (IMT) and carotid plaques. Despite the fact that aPLs can promote both thrombotic and obstetric complications, some pathogenic differences have been documented between the two entities. This study aimed to evaluate whether the atherosclerotic risk differs between subjects with obstetric and thrombotic APS. Methods A total of 167 APS women (36 obstetric and 131 thrombotic) were compared with 250 aPLs negative controls. IMT of the common carotid artery (CCA) and of the bulb and the prevalence of carotid plaques were assessed. Results CCA- and bulb-IMT were significantly higher in women with thrombotic APS, while being similar between the obstetric APS and the controls [CCA-IMT: mean (s.d.) 0.97 (0.49), 0.78 (0.22) and 0.81 (0.12) mm for the thrombotic, obstetric and control groups, respectively, P < 0.001 between thrombotic and controls, P = 0.002 between thrombotic and obstetric; bulb-IMT: mean (s.d.) 1.38 (0.79), 0.96 (0.27) and 0.96 (0.51) mm for the thrombotic, obstetric and control groups, P < 0.001]. Women with thrombotic APS had significantly increased risk of presenting carotid plaques. This risk was significantly lower in obstetric APS. Conclusion Unlike thrombotic APS, obstetric APS is not associated with an increase of markers of subclinical atherosclerosis. If confirmed on wider populations, these results could suggest different pathogenetic role of aPLs in promoting atherosclerosis in vascular and obstetric APS, and raise questions on the risk–benefit profile of thromboprophylaxis in obstetric APS outside pregnancy periods.

Funder

public, commercial or not-for-profit sectors

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Reference33 articles.

1. Antiphospholipid syndrome;Cervera;Thromb Res,2017

2. Antiphospholipid syndrome;Ruiz-Irastorza;Lancet,2010

3. Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis;Cheng;Intern Emerg Med,2019

4. Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms;Pierangeli;Curr Opin Hematol,2006

5. Cardiac manifestations of antiphospholipid syndrome: clinical presentation, role of cardiac imaging, and treatment strategies;Tufano;Semin Thromb Hemost,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3